Journey Medical (DERM) Other Non Operating Income (2021 - 2026)
Journey Medical's (DERM) quarterly Other Non Operating Income came in at -$3000.0 in Q1 2026, up 57.14% YoY from -$1909.1 in Q1 2025, and up 98.54% on a QoQ basis from -$206000.0 in Q4 2025.
Journey Medical (DERM) Other Non Operating Income (2021 - 2026) Analysis & Trends
Journey Medical (DERM) has 6 years of Other Non Operating Income data on file, last reported at -$3000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 57.14% year-over-year to -$3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$273000.0 (down 125.14% YoY) and the FY2025 annual result came in at -$277000.0, down 124.62% from the prior year.
- Other Non Operating Income rose to -$3000.0 in Q1 2026, from -$206000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.1 million in Q3 2024 to a low of -$206000.0 in Q4 2025.
- A 5-year average of $37142.9 and a median of -$27000.0 in 2022 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income tumbled 1000.0% — and 2024, when it surged 1213.86%.
- Tracing DERM's Other Non Operating Income over 5 years: stood at -$67000.0 in 2022, then soared by 97.01% to -$2000.0 in 2023, then jumped by 56350.0% to $1.1 million in 2024, then sank by 118.31% to -$206000.0 in 2025, then soared by 98.54% to -$3000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$3000.0 (Q1 2026), -$206000.0 (Q4 2025), and -$3000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Journey Medical | 202.90 Mn | 177.26 Mn | 12.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -206,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -61,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | -32,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | -101,000.00 |
| Jun 30, 2023 | -33,000.00 |
| Mar 31, 2023 | -47,000.00 |
| Dec 31, 2022 | -67,000.00 |
| Sep 30, 2022 | -22,000.00 |
| Dec 31, 2021 | -263,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Jun 30, 2021 | -182,000.00 |